Kansas Hospital Live on Evident EHR and TruBridge RCM Services to Better Manage Patient Care and Improve Financial Performance

MOBILE, Ala.–(BUSINESS WIRE)–Evident LLC, a wholly owned subsidiary of CPSI (NASDAQ: CPSI) and a leading provider of electronic health record (EHR) systems and services, announced today that Girard Medical Center is live on the Evident cloud-hosted EHR solution. Based in Girard, Kansas, the facility is now running the full suite of Evident clinical and financial applications to support operations in both its inpatient and emergency room settings along with ancillary areas of care including pharmacy and radiology. In addition, Girard implemented the Revenue Cycle Management (RCM) product suite and is using the companion Early Out Service, both offered through sister company, TruBridge.

The 25-bed critical access hospital (CAH) with a 10-bed Senior Behavioral Health unit, provides an array of services to support inpatient and outpatient care to the City of Girard and surrounding communities. Girard Medical Center initially purchased Evident’s workforce management solution to give its human resource and business office staff much needed efficiencies in running payroll, tracking employee time and staff shift scheduling. After seeing the positive impact of these workforce management solutions, Girard Medical Center realized it wanted to expand its technology investment with Evident. Girard Medical Center wanted a modern, advanced fully integrated EHR system to provide its entire staff with the efficiencies needed to better manage patient care and back-office operations. Prior to implementing Evident, its current systems were outdated and dispersed between vendors with varying capabilities.

“Our goal at Girard Medical Center is to provide our patient community with accessible, compassionate and high-quality care. Providing our clinical staff with the tools they need that are intuitive to their workflows and provide one complete view of patient data across various points of care will help us continue to meet that goal,” said Ruth Duling, chief executive officer of Girard Medical Center.

“Having a solid financial performance is critical for us to effectively serve the healthcare needs of the communities in Southeast Kansas. We are confident in the products and services from TruBridge to give our business office the support they need to improve our cash flow, achieve greater speed of payment and ultimately keep us on solid financial footing,” said Holly Koch, chief financial officer of Girard Medical Center.

Boyd Douglas, president and chief executive officer of CPSI, said, “We continue to invest in product innovation, and it shows. There is proven value in doing business with one company that offers a comprehensive clinical, financial and RCM solution set along with on-going support that our clients need to advance and improve community healthcare. It is our privilege to partner with Girard Medical Center.”

About Evident

Evident, a member of the CPSI family of companies, recognizes the challenges hospitals, clinics and other healthcare providers face – the need for simplicity, cost containment and delivery of a quality healthcare experience for patients and physicians alike. Our integrated software solutions are backed by a proactive support approach, making us the partner of choice for hundreds of healthcare organizations. For more information, visit www.evident.com.

About TruBridge

TruBridge, a member of the CPSI family of companies, provides business and consulting services, and an end-to-end Revenue Cycle Management (RCM) solution. With our arsenal of RCM offerings that include an HFMA Peer Reviewed® product and an HFMA Peer Reviewed® complete outsourcing service, TruBridge helps hospitals, physician clinics, and skilled nursing organizations of all sizes become more efficient at serving their communities. For further information, visit www.trubridge.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “projects,” “targets,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the ability of Evident and TruBridge to successfully partner with Girard Medical Center and implement the Evident and TruBridge solutions are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: risks related to the timing of the implementation of the Evident’s and TruBridge’s solutions at Girard Medical Center and the ability of Evident’s EHR solution to create clinical efficiencies and improve decision-making and of TruBridge’s collection services to improve patient billing and collections systems at Girard Medical Center; the impact of the ongoing COVID-19 pandemic and related economic disruptions which have materially affected CPSI’s revenue and could materially affect CPSI’s gross margin and income, as well as CPSI’s financial position and/or liquidity; actions to be taken by CPSI in response to the pandemic; the legal, regulatory and administrative developments that occur at the federal, state and local levels; changes in revenues due to declining hospital demand and deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients); CPSI’s potential inability to attract and retain qualified client service and support personnel, as well as the disruptive effect of sales force restructurings; exposure to numerous laws, regulations and other requirements through CPSI’s international business activities; potential failure to develop or enhance products in response to market demands, as well as undetected errors or problems in new products or enhancements; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of CPSI’s or its partners’ information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; dependence on licenses of rights, products and services from third parties; service interruptions resulting from loss of power and/or telecommunications capabilities; potential increased expenses related to labor or other expenditures; and the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms or at all, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financial perspective. Numerous other risks, uncertainties and other factors may cause actual results to differ materially from those expressed in any forward-looking statements. Such factors include risk factors described from time to time in CPSI’s public releases and reports filed with the Securities and Exchange Commission, including but not limited to, CPSI’s most recent Annual Report on Form 10-K. We also caution investors that the forward-looking information described herein represents CPSI’s outlook only as of this date, and CPSI undertakes no obligation to update or revise any forward-looking statements to reflect events or development after the date of this press release.

Contacts

Tracey Schroeder

Chief Marketing Officer

tracey.schroeder@cpsi.com
(251) 639-8100